Notable Labs, Ltd. Ordinary Shares
NTBL
NTBL was delisted on the 22nd of October, 2024.
20 hedge funds and large institutions have $3.2M invested in Notable Labs, Ltd. Ordinary Shares in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
86% more capital invested
Capital invested by funds: $1.72M → $3.2M (+$1.48M)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
5% less funds holding
Funds holding: 21 → 20 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$925K |
| 2 |
Renaissance Technologies
New York
|
+$591K |
| 3 |
Millennium Management
New York
|
+$283K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$29K |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$28.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$246K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$28K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$18K |
| 4 |
MML Investors Services
Springfield,
Massachusetts
|
-$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.96K |
NTBL Hedge Fund Activity: Q2 2020 in Review
20 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Notable Labs, Ltd. Ordinary Shares (NTBL) for Q2 2020, worth a combined $3.2M — up 86% from $1.72M a quarter earlier.
Fund positioning in NTBL was balanced in Q2 2020: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $925K. The largest seller was CVI Holdings, exiting entirely with an estimated $246K sold.
- 20 institutional investors held Notable Labs, Ltd. Ordinary Shares (NTBL) as of Q2 2020, down from 21 in Q1 2020.
- Funds reported $3.2M of Notable Labs, Ltd. Ordinary Shares stock for Q2 2020, up 86% quarter-over-quarter.
- 5 funds opened new Notable Labs, Ltd. Ordinary Shares positions in Q2 2020 and 5 closed out, a net change of 0 holders.
- The largest Notable Labs, Ltd. Ordinary Shares buyer in Q2 2020 was Morgan Stanley, an estimated $925K added.
- The largest Notable Labs, Ltd. Ordinary Shares seller in Q2 2020 was CVI Holdings, an estimated $246K sold.
Based on aggregated 13F filings for Q2 2020.